Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials

Abstract Background Surrogate endpoints, such as those of interest in chronic kidney disease (CKD), are often evaluated using Bayesian meta-regression. Trials used for the analysis can evaluate a variety of interventions for different sub-classifications of disease, which can introduce two additiona...

Full description

Bibliographic Details
Main Authors: Willem Collier, Benjamin Haaland, Lesley A. Inker, Hiddo J.L. Heerspink, Tom Greene
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:https://doi.org/10.1186/s12874-024-02170-0
_version_ 1827327037993385984
author Willem Collier
Benjamin Haaland
Lesley A. Inker
Hiddo J.L. Heerspink
Tom Greene
author_facet Willem Collier
Benjamin Haaland
Lesley A. Inker
Hiddo J.L. Heerspink
Tom Greene
author_sort Willem Collier
collection DOAJ
description Abstract Background Surrogate endpoints, such as those of interest in chronic kidney disease (CKD), are often evaluated using Bayesian meta-regression. Trials used for the analysis can evaluate a variety of interventions for different sub-classifications of disease, which can introduce two additional goals in the analysis. The first is to infer the quality of the surrogate within specific trial subgroups defined by disease or intervention classes. The second is to generate more targeted subgroup-specific predictions of treatment effects on the clinical endpoint. Methods Using real data from a collection of CKD trials and a simulation study, we contrasted surrogate endpoint evaluations under different hierarchical Bayesian approaches. Each approach we considered induces different assumptions regarding the relatedness (exchangeability) of trials within and between subgroups. These include partial-pooling approaches, which allow subgroup-specific meta-regressions and, yet, facilitate data adaptive information sharing across subgroups to potentially improve inferential precision. Because partial-pooling models come with additional parameters relative to a standard approach assuming one meta-regression for the entire set of studies, we performed analyses to understand the impact of the parameterization and priors with the overall goals of comparing precision in estimates of subgroup-specific meta-regression parameters and predictive performance. Results In the analyses considered, partial-pooling approaches to surrogate endpoint evaluation improved accuracy of estimation of subgroup-specific meta-regression parameters relative to fitting separate models within subgroups. A random rather than fixed effects approach led to reduced bias in estimation of meta-regression parameters and in prediction in subgroups where the surrogate was strong. Finally, we found that subgroup-specific meta-regression posteriors were robust to use of constrained priors under the partial-pooling approach, and that use of constrained priors could facilitate more precise prediction for clinical effects in trials of a subgroup not available for the initial surrogacy evaluation. Conclusion Partial-pooling modeling strategies should be considered for surrogate endpoint evaluation on collections of heterogeneous studies. Fitting these models comes with additional complexity related to choosing priors. Constrained priors should be considered when using partial-pooling models when the goal is to predict the treatment effect on the clinical endpoint.
first_indexed 2024-03-07T14:55:12Z
format Article
id doaj.art-2415e4fba1da44b68fc33af09146b0c3
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-03-07T14:55:12Z
publishDate 2024-02-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-2415e4fba1da44b68fc33af09146b0c32024-03-05T19:28:46ZengBMCBMC Medical Research Methodology1471-22882024-02-0124111710.1186/s12874-024-02170-0Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trialsWillem Collier0Benjamin Haaland1Lesley A. Inker2Hiddo J.L. Heerspink3Tom Greene4Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern CaliforniaDepartment Population Health Sciences, University of Utah School of MedicineDivision of Nephrology, Tufts University Medical CenterDepartment of Clinical Pharmacy and Pharmacology, Department of Nephrology, University of GroningenDepartment Population Health Sciences, University of Utah School of MedicineAbstract Background Surrogate endpoints, such as those of interest in chronic kidney disease (CKD), are often evaluated using Bayesian meta-regression. Trials used for the analysis can evaluate a variety of interventions for different sub-classifications of disease, which can introduce two additional goals in the analysis. The first is to infer the quality of the surrogate within specific trial subgroups defined by disease or intervention classes. The second is to generate more targeted subgroup-specific predictions of treatment effects on the clinical endpoint. Methods Using real data from a collection of CKD trials and a simulation study, we contrasted surrogate endpoint evaluations under different hierarchical Bayesian approaches. Each approach we considered induces different assumptions regarding the relatedness (exchangeability) of trials within and between subgroups. These include partial-pooling approaches, which allow subgroup-specific meta-regressions and, yet, facilitate data adaptive information sharing across subgroups to potentially improve inferential precision. Because partial-pooling models come with additional parameters relative to a standard approach assuming one meta-regression for the entire set of studies, we performed analyses to understand the impact of the parameterization and priors with the overall goals of comparing precision in estimates of subgroup-specific meta-regression parameters and predictive performance. Results In the analyses considered, partial-pooling approaches to surrogate endpoint evaluation improved accuracy of estimation of subgroup-specific meta-regression parameters relative to fitting separate models within subgroups. A random rather than fixed effects approach led to reduced bias in estimation of meta-regression parameters and in prediction in subgroups where the surrogate was strong. Finally, we found that subgroup-specific meta-regression posteriors were robust to use of constrained priors under the partial-pooling approach, and that use of constrained priors could facilitate more precise prediction for clinical effects in trials of a subgroup not available for the initial surrogacy evaluation. Conclusion Partial-pooling modeling strategies should be considered for surrogate endpoint evaluation on collections of heterogeneous studies. Fitting these models comes with additional complexity related to choosing priors. Constrained priors should be considered when using partial-pooling models when the goal is to predict the treatment effect on the clinical endpoint.https://doi.org/10.1186/s12874-024-02170-0Surrogate endpointMeta-regressionBayesian hierarchical modelingChronic kidney disease
spellingShingle Willem Collier
Benjamin Haaland
Lesley A. Inker
Hiddo J.L. Heerspink
Tom Greene
Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
BMC Medical Research Methodology
Surrogate endpoint
Meta-regression
Bayesian hierarchical modeling
Chronic kidney disease
title Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
title_full Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
title_fullStr Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
title_full_unstemmed Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
title_short Comparing Bayesian hierarchical meta-regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
title_sort comparing bayesian hierarchical meta regression methods and evaluating the influence of priors for evaluations of surrogate endpoints on heterogeneous collections of clinical trials
topic Surrogate endpoint
Meta-regression
Bayesian hierarchical modeling
Chronic kidney disease
url https://doi.org/10.1186/s12874-024-02170-0
work_keys_str_mv AT willemcollier comparingbayesianhierarchicalmetaregressionmethodsandevaluatingtheinfluenceofpriorsforevaluationsofsurrogateendpointsonheterogeneouscollectionsofclinicaltrials
AT benjaminhaaland comparingbayesianhierarchicalmetaregressionmethodsandevaluatingtheinfluenceofpriorsforevaluationsofsurrogateendpointsonheterogeneouscollectionsofclinicaltrials
AT lesleyainker comparingbayesianhierarchicalmetaregressionmethodsandevaluatingtheinfluenceofpriorsforevaluationsofsurrogateendpointsonheterogeneouscollectionsofclinicaltrials
AT hiddojlheerspink comparingbayesianhierarchicalmetaregressionmethodsandevaluatingtheinfluenceofpriorsforevaluationsofsurrogateendpointsonheterogeneouscollectionsofclinicaltrials
AT tomgreene comparingbayesianhierarchicalmetaregressionmethodsandevaluatingtheinfluenceofpriorsforevaluationsofsurrogateendpointsonheterogeneouscollectionsofclinicaltrials